Quantification of nuclear transport inhibition by SARS-CoV-2 ORF6 using a broadly applicable live-cell dose-response pipeline
The paper quantifies how SARS-CoV-2 ORF6 inhibits nuclear transport and finds it is more potent than SARS-CoV-1 ORF6 due to differences in its C-terminal region.